Ho Sze Chun Winson 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jan 14, 2021
Insider Transaction Report
Form 4
Ho Sze Chun Winson
Director
Transactions
- Award
Options to Purchase Common Stock
2021-01-06+50,000→ 50,000 totalExercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
Holdings
- 33,333
Options to Purchase Common Stock
Exercise: $1.68From: 2018-08-04Exp: 2023-08-04→ Common (33,333 underlying) - 8,333
Options to Purchase Common Stock
Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying)